dentinstitute.com valid

Dent Neurologic

Center for Neurologic Excellence

For agents: Dent Neurologic, a neurology center offering patient policies, intake forms and clinical study information such as RECOVER and DIMENSION trials.

neurologyclinical-studiespatient-formshuntingtons-diseasedepression-research

Their llms.txt

The beginning of the file, from our validated copy saved 2026-10-20T18:47:42.349Z. Cached copy · Source on dentinstitute.com

Generated by All in One SEO v4.9.5.1, this is an llms.txt file, used by LLMs to index the site.

# Dent Neurologic

Center for Neurologic Excellence

## Sitemaps

- [XML Sitemap](https://www.dentinstitute.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [ARGENX Platform trial](https://www.dentinstitute.com/argenx-platform-trial/) - ARGENX Platform trial About this clinical research study: Adapt Forward is a platform of studies designed for people living with MG. It consists of several studies that are meant to evaluate how different combinations and regimens of MG drugs may work (also known as efficacy) and how safe they are for the use in adults
- [COMPASS PATHWAYS COMP-006](https://www.dentinstitute.com/compass-pathways-comp006/) - COMPASS PATHWAYS COMP-006 About the phase 2b trial: This randomised controlled phase 2b study of investigational psilocybin treatment in treatment-resistant depression is the largest psilocybin treatment clinical trial ever conducted, with 233 patients across 22 sites in 10 countries across Europe and North America. This trial assessed the safety and efficacy of COMP360 psilocybin treatment in three
- [ANNOVIS Alzheimer's Disease](https://www.dentinstitute.com/annovis/) - ANNOVIS Alzheimer's Disease What is the ANNOVIS Alzheimer's Disease Study? A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD The Goal The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer’s disease in adults aged 55-85. It will also learn about the safety
- [Roche/Genentech PARAISO](https://www.dentinstitute.com/roche-genentech-paraiso/) - Roche/Genentech PARAISO Why is the study needed? Paraiso is study to compare prasinezumab with a placebo in people with early-stage Parkinson’s disease who are taking levodopa to manage their disease symptomsParkinson’s disease (PD) is a long-term condition that gets worse over time. In PD, a naturally occurring protein called alpha-synuclein does not form properly. It sticks together
- [Cartesian Aurora](https://www.dentinstitute.com/cartesian-aurora/) - Cartesian Aurora What is the AURORA Study? The aim of the AURORA Study is to assess the safety and effectiveness of an mRNA CAR T-cell therapy, known as Descartes-08, as a potential approach to treat generalized myasthenia gravis. Myasthenia gravis is an autoimmune disease, which means that the immune system mistakenly produces antibodies (proteins that
- [ArgenX Empassion](https://www.dentinstitute.com/argenx-empassion/) - ArgenX Empassion The Empassion study is designed to assess how safe and effective an investigational study drug, empasiprubart, is compared to intravenous immunoglobulin (IVIg) as a possible treatment for adults living with multifocal motor neuropathy (MMN).The clinical study is looking to enroll up to 100 participants across the world. Enrolled participants will be asked to
- [World Stroke Day](https://www.dentins
…

Related sites

Other listed sites in Healthcare. See the whole category →

Machine-readable: GET /v1/resolve?q=dentinstitute.com · GET /v1/domain/dentinstitute.com · this page as Accept: application/json or text/markdown · MCP lookup_domain

Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.

Claim my listing on Agent Web Map for dentinstitute.com:
1. POST https://agentwebmap.com/v1/sites/dentinstitute.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://dentinstitute.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/dentinstitute.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/dentinstitute.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verify

Corrections or removal requests: contact the directory.